I know very little of them so far, but they fascinate me. So, therefore, I will make each a tiny (1/1,000th) position in my holdings to be able to track them and get some skin in the game.
I have been reading 100 Baggers by Christopher Mayer and wanted to apply a few things I am learning from it to real-life -- just on a small scale for now.
Found these with a finviz screener using the following:
- Market cap under $10B
- Price over $3
- 5-year sales growth over 25%
- QoQ sales growth over 25%
- Return on Equity over 25%
These purchases will act mainly as a watchlist, but I will add funds and revisit them for more research if any of these double.
What fascinates me about each:
- eXp offers optionality within the metaverse
- Medifast has obesity issues providing a tailwind here in the US
- InMode owns a 46% profit margin
- Lovesac: the $CROX of furniture?
- Progyny's fertility-focused offerings seem very niche but invaluable to those who need it
- XPEL is up 410x in the last decade 🤯
The 3-year sales growth rates (CAGR) on these stocks range from 33% to 96%, while their Return on Equities run from 31% to 91%.
What do you all think of this strategy?